Figure 3: Emerging indications and research frontiers for GLP-1s Neurodegenerative diseases One of the most closely watched areas is GLP-1s potential in treating neurodegenerative diseases
Following up with your provider regularly so they can adjust your dose, help manage side effects, and track your progress
For real-world adherence, that's a bigger deal than it sounds
The Market Effects of Weight-Loss Drugs Have Only Just Begun Nonetheless, so startling and immediate is the financial impact for manufacturers that Lars Fruergaard Jorgensen, A/S CEO of Novo Nordisk the Danish company that manufactures Ozempic reported fielding calls from executive counterparts at food companies who were wary (and worried) of the long-term impact of the weight-loss drugs on their businesses
Details are yet to be confirmed but there are likely to be strict criteria regarding BMI and other health conditions
This means that they will not face the opposition or stigma that has severely limited access to methadone, despite clear medical and public health evidence of benefits from easing prescribing restrictions
